These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 27825460)
21. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry. Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201 [TBL] [Abstract][Full Text] [Related]
22. The epidemiology of Waldenström macroglobulinemia. McMaster ML Semin Hematol; 2023 Mar; 60(2):65-72. PubMed ID: 37099032 [TBL] [Abstract][Full Text] [Related]
23. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow. Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024 [TBL] [Abstract][Full Text] [Related]
24. Targeting the bone marrow in Waldenstrom macroglobulinemia. Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa GC; Leleu X; Roccaro AM Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S65-9. PubMed ID: 22035751 [TBL] [Abstract][Full Text] [Related]
32. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases. Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295 [TBL] [Abstract][Full Text] [Related]
33. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma. Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885 [TBL] [Abstract][Full Text] [Related]
34. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection. Kapoor P; Paludo J; Ansell SM Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591 [TBL] [Abstract][Full Text] [Related]
35. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia]. Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358 [TBL] [Abstract][Full Text] [Related]
36. Role of plasma cells in Waldenström macroglobulinaemia. El-Ayoubi A; Wang JQ; Hein N; Talaulikar D Pathology; 2017 Jun; 49(4):337-345. PubMed ID: 28483372 [TBL] [Abstract][Full Text] [Related]
38. Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM. Gavriatopoulou M; Terpos E; Ntanasis-Stathopoulos I; Papasotiriou I; Fotiou D; Migkou M; Roussou M; Kanellias N; Ziogas D; Dialoupi I; Eleutherakis Papaiakovou E; Kastritis E; Dimopoulos MA Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):23-28. PubMed ID: 30224328 [TBL] [Abstract][Full Text] [Related]
39. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia. Shiokawa S; Suehiro Y; Uike N; Muta K; Nishimura J Am J Hematol; 2001 Nov; 68(3):139-43. PubMed ID: 11754393 [TBL] [Abstract][Full Text] [Related]
40. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]